Skip to content

Altimmune ALT Change in AP

Change in AP at other companies

Eli Lilly logo
Eli LillyLLY
$2.55B+290%
Merck & Co. logo
Merck & Co.MRK
$27.5M-39.6%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$3.58M+332%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$13.93M+760%
Wave Life Sciences logo
Wave Life SciencesWVE
$3.29M+260%
Delcath Systems logo
Delcath SystemsDCTH
-$273K+70.5%

Other financials

Income statement

See full
Revenue$26.0K+420%
Operating income-$24.2M-11.1%
Net income-$22.6M-15.3%
EPS (diluted)-$0.18+30.8%

Balance sheet

See full
Cash & equivalents$97.6M+98.7%
Total debt$34.8M+14,092%
Total equity$284.0M+99.8%
Total assets$335.6M+113%

Cash flow

See full
Operating cash flow-$20.9M-24.4%
CapEx$21.0K
Free cash flow-$21.0M

Valuation

See full
Market cap$558.14M-2.1%
Enterprise value$495.27M-5.0%
P/S13,613.2×-24,380×

Profitability

See full
Operating margin-230,461%-82,087pp
Net margin-214,861%-76,057pp
FCF margin-17,806.8%-110,030pp

Returns & leverage

See full
Return on equity-42.7%-8.7pp
Debt / equity0.1×+0.1×
Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Altimmune's change in AP?
Altimmune (ALT) reported change in AP of -$1.19M in Q1 2026.
How has Altimmune's change in AP changed year-over-year?
Altimmune's change in AP decreased by 237.1% year-over-year, from $866K to -$1.19M.
What is the long-term trend for Altimmune's change in AP?
Over 3 years (2021 to 2024), Altimmune's change in AP has grown at a 9.3% compound annual growth rate (CAGR), from $1.42M to -$1.86M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.